Venture Capital

Aegera Therapeutics - Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.

Immunochina - Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.

Cyagen Biosciences - Cyagen Biosciences specializes in genetically modified rodent models, cell, and gene therapy solutions for research and development.

Mediphage Bioceuticals - Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.

Orgenesis - Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.

Congruence Therapeutics - Congruence Therapeutics operates as a biotechnology company.

Ucello Therapeutics - Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.

PeLeMed - PeLeMed is a drug development company working on the discovery of anti-cancer drugs.

OncoGenex - OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.

New Radiomedicine Technology - Chengdu New Radiomedicine Technology is a Chinese medical isotopes provider.

© 2025 bioDAO.ai